European Journal of Radiology
Volume 72, Issue 2 , Pages 289-294 , November 2009

Interdisciplinary consensus on the uses and technique of MR-guided vacuum-assisted breast biopsy (VAB): Results of a European consensus meeting

  • Sylvia H. Heywang-Köbrunner

      Affiliations

    • Center for Breast Diagnosis Munich, Radiologie Haidhausen, Medizinisches Versorgungszentrum, Einsteinstr. 1, 81675 München, Germany
    • Reference Center for Mammography Munich, Einsteinstr. 3, 81675 München, Germany
    • Corresponding Author InformationCorresponding author at: Reference Center for Mammography Munich, Einsteinstr. 3, 81675 München, Germany. Tel.: +49 89 961 661 330; fax: +49 89 961 661 340.
  • ,
  • Ruchi Sinnatamby

      Affiliations

    • Cambridge University, Box 97, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK
  • ,
  • Annette Lebeau

      Affiliations

    • Department of Pathology, University Medical Center Hamburg-Eppendorf, Martinistr. 52, D-20246 Hamburg, Germany
  • ,
  • Antje Lebrecht

      Affiliations

    • Department of Obstetrics and Gynaecology, Johannes Gutenberg-University Mainz, Langenbeckstr. 1, D-55131 Mainz, Germany
  • ,
  • Peter D. Britton

      Affiliations

    • Cambridge University, Box 97, Addenbrooke's Hospital, Cambridge CB2 2QQ, UK
  • ,
  • Ingrid Schreer

      Affiliations

    • Mammazentrum des Universitätsklinikums Schleswig-Holstein, Campus Kiel, Fachbereich Medizin, Michaelisstr. 16, 24105 Kiel, Germany
  • ,
  • Consensus Group

Received 13 May 2008 ,Revised 2 July 2008 ,Accepted 8 July 2008.

References 

  1. National Institute for Clinical Excellence (NICE), National Collaborating Centre for Primary Care, 2006. Familial breast cancer: Familial breast cancer. The classification and care of women at risk of familial breast cancer in primary, secondary and tertiary care http://guidance.nice.org.uk/cg41/guidance/pdf.
  2. National Comprehensive Cancer Network (NCCN), 2007. NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast and Ovarian. V.I. http://www.nccn.org/.
  3. Saslow D, et al. American cancer society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin. 2007;57:75–89
  4. ACR 2004 practice guideline for the performance of Magnetic Resonance Imaging (MRI) of the breast. ACR practice Guideline (www.acr.org) (Res. 11) Effective 10.01.2004: Amended 2006 (Res. 35) 517–522.
  5. AG-Mammdiagnostik der D.R.G. . Recommendations for MR-mammography (Mitteilungen der DRG). Fortschr Röntgenstr. 2005;177:474–475doi:10.1055/s-2005-864763
  6. Kriege M, et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med. 2004;351:427–437
  7. Kuhl CK, Morakkabati N, Leutner CC, Schmiedel A, Wardelmann E, Schild HH. MR imaging-guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology. 2001;220(Jully (1)):31–39
  8. Lampe D, Hefler L, Alberich T, et al. The clinical value of preoperative wire localization of breast lesions by magnetic resonance imaging—a multicenter study. Breast Cancer Res Treat. 2002;75(2):175–179
  9. Leach MO, et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer—a prospective multicentre cohort study (MARIBS). Lancet. 2005;365(9473):1769–1778
  10. Lehman CD, Blume JD, Thickman D, et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) trial. J Surg Oncol. 2005;92(1):9–151
  11. Lehman CD, et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med. 2007;356(13):1295–130329
  12. Liberman L, Mason G, Morris EA, Dershaw DD. Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol. 2006;186(2):426–430
  13. Perlet C, Heywang-Kobrunner SH, Heinig A, et al. Magnetic resonance-guided, vacuum-assisted breast biopsy: results from a European multicenter study of 538 lesions. Cancer. 1. 2006;106(5):982–9901
  14. Sardanelli F, et al. Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology. 2007;242(3):698–715
  15. Tan JE, Orel SG, Schnall MD, Schultz DJ, Solin LJ. Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol. 1999;22:414–418
  16. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA. 2004;292:1317–1325
  17. LaTrenta LR, Menell JH, Morris EA, Abramson AF, Dershaw DD, Liberman L. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology. 2003;227(3):856–861
  18. Fischer U, Kopka L, Grubbe E. Magnetic resonance-guided localization and biopsy of suspicious breast lesions. Top Magn Reson Imaging. 1998;9:44–59
  19. Heywang-Köbrunner SH, Huynh AT, Viehweg P, Hanke W, Requardt H, Paprosch I. Prototype breast coil for MRI-guided needle localization. J Comput Assist Tomogr. 1994;18:876–888
  20. Heywang-Köbrunner SH, Heinig A, Pickuth D, et al. Interventional MRI of the breast: lesion localization and biopsy. Eur Radiol. 2000;10:36–45
  21. Kuhl CK, Morakkabati N, Leutner CC, Schmiedel A, Wardelmann E, Schild HH. MR imaging-guided large-core (14-gauge) needle biopsy of small lesions visible at breast MR imaging alone. Radiology. 2001;220(1):31–39
  22. Lo LD, Orel SG, Schnall MD. MR imaging-guided interventions in the breast. MRI Clinica North Am. 2001;9(2):373–380
  23. deSouza NM, Coutts GA, Puni RK, Young IR. Magnetic resonance imaging-guided breast biopsy using a frameless stereotactic technique. Clin Radiol. 1996;51:425–428
  24. Warren RM, Hayes C. Localization of breast lesions shown only on MRI—a review for the UK study of MRI screening for breast cancer advisory group of MARIBS. Br J Radiol. 2000;73:123–132
  25. Heywang-Köbrunner SH, Heinig A, Schaumlöffel U, et al. MRI-guided percutaneous excisional and incisional biopsy (PEIB) of breast lesions. Eur Radiol. 1999;9(8):1656–1665
  26. Prat X, Sittek H, Grosse A, et al. European quadricentric evaluation of a breast MR biopsy and localization device: technical improvements based on phase I evaluation. Eur Radiol. 2002;12:1720–1727
  27. Tozaki M, Yamashiro N, Fukuma E . MR-guided vacuum-assisted breast biopsy using a non-titanium needle. Magn Reson Med Sci. 2007;6:259–264
  28. Daniel BL, Freeman LJ, Pyzoha JM, et al. An MRI-compatible semiautomated vacuum-assisted breast biopsy system: initial feasibility study. J Magn Reson Imaging. 2005;21(5):637–644
  29. Gebauer B, Bostanjoglo M, Moesta KT, Schneider W, Schlag PM, Felix R. Magnetic resonance-guided biopsy of suspicious breast lesions with a handheld vacuum biopsy device. Acta Radiol. 2006;47(November (9)):907–913
  30. Hauth EA, Reiter K, Hoffmann O, Otterbach F, Kimmig R, Forsting M. MRI-guided vacuum-assisted breast biopsy. Zentralbl Gynakol. 2005;127(6):400–406
  31. Lehman CD, Deperi ER, Peacock S, McDonough MD, Demartini WB, Shook J. Clinical experience with MRI-guided vacuum-assisted breast biopsy. AJR. 2005;184:1782–1787
  32. Liberman L, Morris EA, Dershaw DD, Thornton CM, Van Zee KJ, Tan LK. Fast MRI-guided vacuum-assisted breast biopsy: initial experience. Am J Roentgenol. 2003;181(5):1283–1293
  33. Orel SG, Rosen M, Mies C, Schnall MD. MR imaging-guided 9-gauge vacuum-assisted breast biopsy: initial experience. Radiology. 2006;238(January (1)):54–61
  34. Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von KarsaF L. . European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis.. Fourth edition. Luxembourg: Office for Official Publications of the European Communities; 2006;ISBN 92-79-01258-4
  35. Silverstein M, et al. International consensus conference on image-detected breast cancer: state of the art diagnosis and treatment. J Am Coll Surg. 2001;193:297–302
  36. EUSOMA. The requirements of a specialist breast unit. Eur J Cancer 2000; 36: 2288–2293.
  37. In:  Schulz KD,  Albert U editor. Updated Stage 3 Guideline for Early Detection of Breast Cancer in Germany. München: W. Zuckschwerdt Verlag; 2008;ISBN 978-3-8603-931-9 (German)
  38. Fahrbach K, Sledge I, Cella C, Linz H, Ross SD. A comparison of the accuracy of two minimally invasive breast biopsy methods—a systematic literature review and meta-analysis. Arch Gynecol Obstet. 2006;274:63–73
  39. Kettritz U, Rotter K, Schreer I, Murauer M, Heywang-Köbrunner SH. Stereotactic vacuum-assisted breast biopsy in 2874 patients—a multicenter study. Cancer. 15 January 2004;100(2):245–251
  40. Amendoeira I, Apostolikas N, Bellocq JP, et al. Quality assurance guidelines for pathology: cytological and histological non-operative procedures. In:  Perry N,  Broeders M,  de Wolf C,  Toernberg S,  Holland R,  von Karsa L editor. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. Luxembourg: Office for Official Publications of the European Communities; 2006;p. 221–256

PII: S0720-048X(08)00390-2

doi: 10.1016/j.ejrad.2008.07.010

European Journal of Radiology
Volume 72, Issue 2 , Pages 289-294 , November 2009